Search

Aim: We conducted the current analysis to determine the potential role of measles vaccination in the context of the spread of COVID-19. Methods: Data were extracted from the world health organization’s (WHO) Global Health Observatory data repository about the measles immunization coverage estimates and correlated to overall morbidity and mortality for COVID-19 among different countries. Data were statistically analyzed to calculate the Spearman rank correlation coefficient (rho). Result: There was no significant correlation between the measles vaccine coverage (%) and both of new cases per one million populations (rho= 0.21; p-value= 0.052) and deaths per one million populations (rho= 0.21; p-value< 0.080) (Figure 1; Figure 2). On further analysis of the effect of the first reported year of vaccination policy, there was no significant correlation with both total cases per one million populations (rho= 0.10; p-value= 0.361) and deaths per one million populations (rho= 0.17; p-value= 0.156). Conclusion: Claims regarding the possible protective effect of measles vaccination seem to be doubtful.

We present the case of a young lady who presented to the department of emergency medicine (DEM) for evaluation of painful breast swelling and skin indurations involving 90% of the body surface. She stayed long in the DEM for 3 days and managed for breast abscess she was consulted to dermatology for evaluation of skin lesions and prelimi- nary diagnosed as rare skin T cell lymphoma. Final diagnosis based on clinical and histopathological was Mycosis Fun- goids (MF).This case reveals that prompt referral from the DEM to the concerned speciality even for the rare type of dis- eases like MF can facilitate diagnosis and management and overall positive impact on disease outlook. Our patient was fi- nally admitted under oncology unit and managed appropriately.